The DOI matches its Crossref record.
Signaling Pathways in Inflammation and Anti-inflammatory Therapies.
Abstract
During the past decade, an abundance of new evidence highlighted the importance of inflammation in the development of chronic pathologies such as neurodegeneration, cancer, diabetes, cardiovascular disease and inflammatory bowel disease. However, most of the current therapies do not address the underlying problem and better therapies are urgently needed. A growing number of researchers have discovered various signaling pathways that are associated with the initiation and progression of inflammation. Among different pathways, we will focus on three classical inflammatory pathways: p38 MAPK, IL-6/JAK/STAT3 and PI3K; and a non-classical inflammatory pathway, the Hippo. Recently, the Hippo pathway has been linked to various inflammatory modulators such as FoxO1/3, TNFα, IL-6, COX2, HIF-1α, AP-1, JAK and STAT. In this review, the molecular mechanisms, associated pathologies and selected drugs (both preclinical and clinical) of these signaling pathways will be summarized. Finally, limitations and potential risks of anti-inflammatory drugs will also be discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, the JAK/STAT signaling pathway can influence neuron reorganization via inflammatory cytokines, BDNF, neurotransmitters, etc., [64].”
Citations
Cited by
Sorted by citations
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
“Preclinical studies have confirmed that methotrexate inhibits lymphocyte proliferation and inflammatory cytokines production via adenosine binding with A2 receptor, which is one of the most important anti-inflammatory mechanisms.(361) Previous systematic reviews and meta-analyses suggested the significant relationship…”
BackgroundSignaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 882
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z., Yi, X., Wei, X., & Jiang, D. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05716-0 · Cited by 626
Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways
Liu, L., Guo, H., Song, A., Huang, J., Zhang, Y., Jin, S., Li, S., Zhang, L., Yang, C., & Yang, P. (2020) · BMC Immunology · doi:10.1186/s12865-020-00355-y · Cited by 293
Pharmacological effects and mechanisms of tannic acid
Wang, J., Xiaolan, C., Chen, Y., Qin, F., & Haifeng, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113561 · Cited by 309
Metadata
- Authors
- Yeung, Y. T., Aziz, F., Guerrero-Castilla, A., & Arguelles, S.
- Affiliations
- China-US (Henan) Hormel Cancer Institute (CN)
- Quimica y Farmacia, Facultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, Iquique 1100000, Chile
- Department of Physiology, Faculty of Pharmacy, University of Seville, Seville, Spain
- ORCID
- Aziz, Faisal
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2018-07-13
- Volume
- 24
- Issue
- 14
- Pages
- 1449-1484
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2795279419
- Cited by
- 530
- References
- 0
- Citations by year
- 2026: 63 · 2025: 96 · 2024: 98 · 2023: 80 · 2022: 88 · 2021: 62 · 2020: 32 · 2019: 7 · 2018: 4
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- inflammation, signaling pathways, anti-inflammatory agents, p38 MAPK, phosphatidylinositol 3-kinase, Hippo signaling pathway, TNF-α, cyclooxygenase-2, HIF-1α, AP-1, chronic disease, adverse drug reactions
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
